Cover Image

Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure

Context: Peroxisome proliferator-activated receptor-γ (PPARγ) is a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors. Activation of PPARγ pathway has been shown to enhance fatty acid oxidation, improve endothelial cell function, and decrease myocardial fibr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rui Chen (Author), Jing Wan (Author), Jing Song (Author), Yan Qian (Author), Yong Liu (Author), Shuiming Gu (Author)
Format:	Book
Published:	Taylor & Francis Group, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
by: Vinesh Sharma, et al.
Published: (2022)

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models
by: Shoichi Kanda, et al.
Published: (2009)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
by: Claudia Sagheddu, et al.
Published: (2021)

Nuclear Receptors as Targets for Drug Development: Peroxisome Proliferator-Activated Receptor γ in Mast Cells: Its Roles in Proliferation and Differentiation
by: Kazutaka Maeyama, et al.
Published: (2005)

The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
by: Jianjun Gao, et al.
Published: (2022)

Effects of Selective Peroxisome Proliferator Activated Receptor Agonists on Corneal Epithelial Wound Healing
by: Yutaro Tobita, et al.
Published: (2021)

Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum
by: Lariah Edwards, et al.
Published: (2019)

Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
by: Shinji Takai, et al.
Published: (2011)

Peroxisome Proliferator-Activated Receptor γ 2 Modulates Late-Pregnancy Homeostatic Metabolic Adaptations
by: Yurena Vivas, et al.
Published: (2016)

Haplotype Analysis of Peroxisome Proliferator-activated Receptor γ Gene Polymorphisms and the Lipoprotein (a) Level
by: Chao SHEN, et al.
Published: (2018)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
by: Tamara Göbel, et al.
Published: (2019)

Antidiabetic and Hypolipidemic Effects of a Novel Dual Peroxisome Proliferator-Activated Receptor (PPAR) α/γ Agonist, E3030, in db/db Mice and Beagle Dogs
by: Shunji Kasai, et al.
Published: (2008)

Insulin Sensitization by a Novel Partial Peroxisome Proliferator-Activated Receptor γ Agonist With Protein Tyrosine Phosphatase 1B Inhibitory Activity in Experimental Osteoporotic Rats
by: Masahiro Kubo, et al.
Published: (2014)

Estimation of peroxisome proliferators - activated receptor γ gene expression in inflammatory skin diseases: atopic dermatitis and psoriasis
by: Doaa Mahgoub, et al.
Published: (2014)

Implication of Peroxisome Proliferator-Activated Receptor γ and Proinflammatory Cytokines in Gastric Carcinogenesis: Link to Helicobacter pylori-Infection
by: Peter C. Konturek, et al.
Published: (2004)

Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis
by: Emerson de Andrade Lima, et al.
Published: (2013)

Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
by: Jung JA, et al.
Published: (2015)

Efficacy and safety of peroxisome proliferator-activated receptor agonists for the treatment of primary biliary cholangitis: a meta-analysis of randomized controlled trials
by: Gang Tang, et al.
Published: (2024)

Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
by: Cao Henian, et al.
Published: (2006)

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1
by: Jung Seok Hwang, et al.
Published: (2012)

Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf
by: Mebrahtom Gebrelibanos Hiben, et al.
Published: (2020)

Nuclear Receptors as Targets for Drug Development: Crosstalk Between Peroxisome Proliferator-Activated Receptor γ and Cytokines in Bone Marrow-Derived Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2005)

The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.
by: Yuqian Luo, et al.
Published: (2020)

Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidation
by: Sen‐bo Yan, et al.
Published: (2023)

The Activation of Peroxisome Proliferator-activated Receptor γ Enhances Insulin Signaling Pathways Via Up-regulating Chemerin Expression in High Glucose Treated HTR-8/SVneo Cells
by: Xuan Zhou, et al.
Published: (2020)

Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
by: Francisco A. Monsalve, et al.
Published: (2013)

Peroxisome Proliferator-Activated Receptor γ (PPARγ ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway
by: Toshio Fujisawa, et al.
Published: (2008)

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
by: Yuan-Ye Qiu, et al.
Published: (2023)

Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin / T Cell Factor (TCF) Pathway in the Mouse Intestine
by: Toshio Fujisawa, et al.
Published: (2008)

Peroxisome proliferator-activated receptors regulate the progression and treatment of gastrointestinal cancers
by: Min Zhang, et al.
Published: (2023)

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
by: Sandeep Tyagi, et al.
Published: (2011)

Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma via the Peroxisome Proliferator-Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway
by: Ying Chen, et al.
Published: (2022)

Falcarindiol Purified From Carrots Leads to Elevated Levels of Lipid Droplets and Upregulation of Peroxisome Proliferator-Activated Receptor-γ Gene Expression in Cellular Models
by: Camilla Bertel Andersen, et al.
Published: (2020)

Danhong Inhibits Oxidized Low-Density Lipoprotein-Induced Immune Maturation of Dentritic Cells via a Peroxisome Proliferator Activated Receptor γ-Mediated Pathway
by: Hongying Liu, et al.
Published: (2012)

Expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ in the lung tissue of obese mice and the effect of rosiglitazone on proinflammatory cytokine expressions in the lung tissue
by: Seung Lok Ryu, et al.
Published: (2013)

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
by: Giuliana Muzio, et al.
Published: (2021)

Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
by: Hui Gao, et al.
Published: (2022)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
by: Triana Espinosa-Jiménez, et al.
Published: (2022)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
by: Juan Decara, et al.
Published: (2020)

Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha
by: Guolin Li, et al.
Published: (2018)